撒哈拉以南非洲静脉血栓栓塞事件与癌症之间关联的流行病学、临床、治疗和进化特性:多哥案例

Y.M. Afassinou , A.A. Adani-Ifè , Y.I. Sossou , S. Pessinaba , B. Atta , M. Pio , S. Baragou , F. Damorou
{"title":"撒哈拉以南非洲静脉血栓栓塞事件与癌症之间关联的流行病学、临床、治疗和进化特性:多哥案例","authors":"Y.M. Afassinou ,&nbsp;A.A. Adani-Ifè ,&nbsp;Y.I. Sossou ,&nbsp;S. Pessinaba ,&nbsp;B. Atta ,&nbsp;M. Pio ,&nbsp;S. Baragou ,&nbsp;F. Damorou","doi":"10.1016/j.jdmv.2023.12.046","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Our study aimed to describe the clinical, paraclinical, therapeutic and outcomes of patients with venous thromboembolic event (VTE) associated with cancer in the context of limited resources.</p></div><div><h3>Materials and methods</h3><p><span>This was a descriptive cross-sectional study over a period of six years from March 1, 2016 to March 31, 2022, in the cardiology<span> department and the oncology unit of the Sylvanus Olympio Teaching Hospital of Lome. Our study examined </span></span>medical records<span><span> of patients who were at least 18 years old and had venous thromboembolic disease and cancer that was histologically confirmed. This study did not include records that were incomplete or records from patients with </span>coronavirus disease.</span></p></div><div><h3>Results</h3><p>Our study included 87 patients with average age of 56.36<!--> <!-->±<!--> <span>15.26 years. The discovery of VTE occurred incidentally in 28.74%. Venous thrombosis<span> was isolated in 68.96% and proximal in 95%. Pulmonary embolism<span> was bilateral in 77.77%. Gynaecological and urological cancers<span><span> were found in 33.33% and 32.19% respectively. Adenocarcinoma was the histological type of cancer found in 47.13%. Cancers were at a very advanced stage in 74.71%. Treatment with </span>antivitamin K was prescribed in 12.65%. In our study, there were 58 patients who passed away with a mortality rate of 66.66%. The cause of death was a complication of VTE in 22.42% and related to the course of cancer in 63.79% of cases.</span></span></span></span></p></div><div><h3>Conclusion</h3><p>VTE during cancer is particular with a fatal evolution due to the severity of VTE and the very advanced stage of cancer.</p></div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 2","pages":"Pages 72-79"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiological, clinical, therapeutic and evolutionary specificities of the association between venous thromboembolic event and cancer in sub-Saharan Africa: Case of Togo\",\"authors\":\"Y.M. Afassinou ,&nbsp;A.A. Adani-Ifè ,&nbsp;Y.I. Sossou ,&nbsp;S. Pessinaba ,&nbsp;B. Atta ,&nbsp;M. Pio ,&nbsp;S. Baragou ,&nbsp;F. Damorou\",\"doi\":\"10.1016/j.jdmv.2023.12.046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Our study aimed to describe the clinical, paraclinical, therapeutic and outcomes of patients with venous thromboembolic event (VTE) associated with cancer in the context of limited resources.</p></div><div><h3>Materials and methods</h3><p><span>This was a descriptive cross-sectional study over a period of six years from March 1, 2016 to March 31, 2022, in the cardiology<span> department and the oncology unit of the Sylvanus Olympio Teaching Hospital of Lome. Our study examined </span></span>medical records<span><span> of patients who were at least 18 years old and had venous thromboembolic disease and cancer that was histologically confirmed. This study did not include records that were incomplete or records from patients with </span>coronavirus disease.</span></p></div><div><h3>Results</h3><p>Our study included 87 patients with average age of 56.36<!--> <!-->±<!--> <span>15.26 years. The discovery of VTE occurred incidentally in 28.74%. Venous thrombosis<span> was isolated in 68.96% and proximal in 95%. Pulmonary embolism<span> was bilateral in 77.77%. Gynaecological and urological cancers<span><span> were found in 33.33% and 32.19% respectively. Adenocarcinoma was the histological type of cancer found in 47.13%. Cancers were at a very advanced stage in 74.71%. Treatment with </span>antivitamin K was prescribed in 12.65%. In our study, there were 58 patients who passed away with a mortality rate of 66.66%. The cause of death was a complication of VTE in 22.42% and related to the course of cancer in 63.79% of cases.</span></span></span></span></p></div><div><h3>Conclusion</h3><p>VTE during cancer is particular with a fatal evolution due to the severity of VTE and the very advanced stage of cancer.</p></div>\",\"PeriodicalId\":53149,\"journal\":{\"name\":\"JMV-Journal de Medecine Vasculaire\",\"volume\":\"49 2\",\"pages\":\"Pages 72-79\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JMV-Journal de Medecine Vasculaire\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2542451323001803\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMV-Journal de Medecine Vasculaire","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2542451323001803","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景我们的研究旨在描述在资源有限的情况下,与癌症相关的静脉血栓栓塞事件(VTE)患者的临床、辅助临床、治疗和预后情况。材料和方法这是一项描述性横断面研究,从2016年3月1日至2022年3月31日的六年间,在洛美西尔瓦努斯-奥林匹奥教学医院的心脏科和肿瘤科进行。我们的研究检查了年满 18 周岁、患有静脉血栓栓塞性疾病和经组织学证实的癌症患者的医疗记录。本研究不包括不完整的病历或冠状病毒病患者的病历。28.74%的患者是偶然发现 VTE 的。68.96%的患者为孤立性静脉血栓,95%为近端静脉血栓。77.77%的患者为双侧肺栓塞。妇科癌症和泌尿科癌症分别占 33.33% 和 32.19%。47.13%的癌症组织学类型为腺癌。74.71%的癌症处于晚期。12.65% 的患者接受了抗维生素 K 治疗。在我们的研究中,有 58 名患者去世,死亡率为 66.66%。结论 由于 VTE 的严重性和癌症的晚期阶段,癌症期间的 VTE 特别具有致命性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Epidemiological, clinical, therapeutic and evolutionary specificities of the association between venous thromboembolic event and cancer in sub-Saharan Africa: Case of Togo

Background

Our study aimed to describe the clinical, paraclinical, therapeutic and outcomes of patients with venous thromboembolic event (VTE) associated with cancer in the context of limited resources.

Materials and methods

This was a descriptive cross-sectional study over a period of six years from March 1, 2016 to March 31, 2022, in the cardiology department and the oncology unit of the Sylvanus Olympio Teaching Hospital of Lome. Our study examined medical records of patients who were at least 18 years old and had venous thromboembolic disease and cancer that was histologically confirmed. This study did not include records that were incomplete or records from patients with coronavirus disease.

Results

Our study included 87 patients with average age of 56.36 ± 15.26 years. The discovery of VTE occurred incidentally in 28.74%. Venous thrombosis was isolated in 68.96% and proximal in 95%. Pulmonary embolism was bilateral in 77.77%. Gynaecological and urological cancers were found in 33.33% and 32.19% respectively. Adenocarcinoma was the histological type of cancer found in 47.13%. Cancers were at a very advanced stage in 74.71%. Treatment with antivitamin K was prescribed in 12.65%. In our study, there were 58 patients who passed away with a mortality rate of 66.66%. The cause of death was a complication of VTE in 22.42% and related to the course of cancer in 63.79% of cases.

Conclusion

VTE during cancer is particular with a fatal evolution due to the severity of VTE and the very advanced stage of cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JMV-Journal de Medecine Vasculaire
JMV-Journal de Medecine Vasculaire Medicine-Cardiology and Cardiovascular Medicine
CiteScore
2.40
自引率
0.00%
发文量
184
期刊介绍: The JMV- Journal de Médecine Vasculaire publishes peer-reviewed clinical and research articles, epidemiological studies, review articles, editorials, guidelines. The journal also publishes abstracts of papers presented at the annual sessions of the national congress of French College of Vascular Pathology.
期刊最新文献
Endovascular treatment of persistent sciatic artery stenoses responsible for critical ischemia. Fenestration of the vertebral artery in a polytrauma patient: A vascular anatomical variant. Financial burden of lymphedema among breast cancer survivors in Iran: A qualitative study. Management challenges of recurrent venous thromboembolism in advanced digestive cancers: Case studies and therapeutic strategies. Reversible cerebral vasoconstriction syndrome following carotid artery revascularization: About three case reports and review of literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1